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SUMMARY. The aim of this study is to determine the predictive capacity of BAFC measurements in the prediction of IVF
outcome with regard to both ovarian response and pregnancy rates. Methods. Transvaginal ultrasound was performed on
day 2–3 of the stimulation cycle, after ovarian down-regulation and before beginning treatment with gonadotropins. All
ovarian follicles measuring 2 mm to 10 mm on both ovaries were counted by a single investigator. Patients were exami-
ned vaginally with an ATL transvaginal transducer (HDI 5000 diagnostic ultrasound system; Bothell, WA; USA). In
total, 85 patients aged 24–42 years who underwent IVF/ICSI cycles were included in this prospective study. The patients
were divided into two groups: group 1 patients who had basal antral follicle count 10 and group 2 patients who had basal
antral follicles >10. Results. Basal antral follicle count correlated directly with number of follicles, number of mature
oocytes, number of embryos and peak E2 levels. We failed to show any significant effect of basal antral follicle count on
pregnancy rates. Furthemore, basal antral follicle count correlated inversely with ampoules of gonadotropin used, days of
stimulation, patient age, and day 3 FSH levels. Nevertheless, transvaginal ultrasound ovarian measurements can predict
poor response, thereby allowing physicians to inform patients that they are at an increased risk for poor stimulation and
cycle cancellation. Physicians can then potentially optimize stimulation protocols. Conclusion. Based on the results of
this study, we suggest using a higher starting dose of gonadotropin in women with an antral follicle count of 10 and a
lower starting dose of gonadotropin in women with an antral follicle count of >10.
Izvorni ~lanak
Klju~ne rije~i: bazalni antralni folikuli, ovarijalni odgovor, stopa trudno}a, ultrazvuk
SA@ETAK. Cilj ovog istra`ivanja je odrediti valjanost mjerenja bazalnih antralnih folikula u pretkazivanju ishoda IVF
glede odgovora ovarija i stopa trudno}a. Metode. Transvaginalni ultrazvuk je ra|en 2.–3. dana stimuliranoga ciklusa,
nakon ovarijalne »down-regulation« i prije po~etka terapije gonadotropinima. Isti pretra`iva~ je u oba jajnika izbrojio sve
folikule veli~ine 2–10 mm. Pacijentice su pregledavane vaginalno pomo}u ATL aparata (HDI 5000 diagnostic ultrasound
system; Bothell, WA; USA). Ukupno je 85 pacijentica dobi 24–42 godine bilo podvrgnuto IVF/ICSI postupku.
Pacijentice su bile podijeljene u dvije skupine: 1. skupina s 10 antralnih bazalnih folikula; i 2. skupina s >10 antralnih
folikula. Rezultati. Broj bazalnih antralnih folikula je direktno korelirao s brojem folikula, brojem zrelih oocita, brojem
postignutih embrija i vr{kom E2. Nismo mogli pokazati znakovit efekt broja bazalnih antralnih folikula na stopu trudno}a.
Nadalje, broj bazalnih antralnih folikula je bio obrnuto proporcionalan s brojem uporabljenih ampula gonadotropina,
danima trajanja stimulacije, dobi pacijentica i razinom FSH-a tre}eg dana. [tovi{e, transvaginalno ultrazvu~no mjerenje
jajnika mo`e pretkazati lo{ odgovor, {to omogu}uje lije~niku da informira pacijenticu o mogu}nosti nedovoljne
stimulacije te da odgodi taj ciklus. Lije~nik tada mo`e optimalno primijeniti protokol stimulacije. Zaklju~ak. Na temelju
rezultata ovog istra`ivanja, preporu~ujemo uporabu vi{e po~etne doze gonadotropina u `ena s brojem antralnih folikula
10 i ni`u po~etnu dozu gonadotropina u `ena s brojem antralnih folikula >10.
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Introduction
Evaluation of ovarian reserve has been the focus of
much clinical research over the past several years.
1–12
Knowing that there is a high risk of a poor outcome of
the IVF treatment may help physicians as well as pa-
tients decide to withdraw from IVF treatment and to
search for alternatives, such as adoption or oocyte dona-
tion. To prevent patients from being wrongly assigned
to poor prognosis group, the markers that will be used
for the prediction of a poor prognosis need to be highly
specific. It would be clinically as well as economically
helpful if there were accurate methods to predict poor
prospects of pregnancy, before entering IVF treatment.
Assessment of ovarian reserve is valuable to determine
stimulation protocols and predicting ART outcome.
Many tests have been evaluated to predict cycle out-
come. Although age is associated with ovarian reserve
and responsiveness, age alone is a weak predictor of IVf
success.
2–5
A variety of hormonal markers has been used
to predict poor ovarian reserve in infertile women. Cy-
cle day 3 FSH, E
2
, and inhibin B, as well as challenge
tests, have been attitude for their predictive value.
6–12
However, despite its increasing acceptance in clinical
practice, these tests are far from perfect in predicting
ovarian response, cancellation rates, and ultimately,
who will or will not get pregnant. Several studies have
demonstrated the predictive value of the hormonal tests
described above.
5–13
Despite its increasing acceptance in
clinical practice, the tests have a variety of shortcom-
ings, including a lack of predictive value of a normal re-
sult. Investigators therefore continue the search for other
markers to identify patients whose ovarian reserve is in-
sufficient for conception. It would be clinically as well
as economically helpful if there were accurate methods
to predict poor prospects of pregnancy, before entering
IVF treatment. Measuring the volume or maximal diam-
eter of both ovaries or counting the number of small
antral follicles by ultrasound has been studied as a
noninvasive and more accurate test in comparison to the
endocrine ovarian reserve tests.
13–16
A low number of
small antral follicles is associated with decreased ovar-
ian response during controlled ovarian hyperstimulation
for IVF, supporting the concept of reduced numbers of
primordial follicles delivering a small antral follicle co-
hort. Moreover, Chang et al.
15
reported a trend toward
lower pregnancy rates in women with few antral folli-
cles. However, this trend lacked statistical significance.
The predictive capacity of AFC for the outcome in IVF
patients has not been assessed systematically. There are
a limited number of studies that assessed the perfor-
mance of AFC in predicting the occurrence of non preg-
nancy and/or poor response. Unfortunately, most of
these studies report on a small number of patients. The
aim of this study is to determine the predictive capacity
of BAFC measurements in the prediction of IVF out-
come with regard to both ovarian response and preg-
nancy rates.
Materials end methods
Between June 2004 and June 2007, a total of 85 pa-
tients at the IVF Unit, The Sistina Medical Center were
found to be eligible for this prospective study. All cou-
ples previously had been evaluated by day 3 hormons
levels, preovulatory US evaluation, hysterosalpingogra-
phy, semen analysis, and hysteroscopy and laparoscopy,
if indicated. The age range of the women was 22–42
years. The predominant diagnoses were male factor,
tubal factor or unexplained infertility.
The inclusion criteria were that the participant had a
normal basal FSH level per our laboratory (<14 mIU/mL),
presence of both ovaries (ability to visualize both ovaries
on transvaginal ultrasonography) and absence of ovarian
abnormalities or ovarian cysts >10 mm. All patients were
included in this study only once to avoid selection bias.
Exclusion criteria were history of ovarian or uterine
surgery, distortions of the uterine cavity or apparent
endometrial pathologies (submucous myoma, synechia,
polyps, Sy PCO) etc. Women with a or who had had
three more failed attempts at IVF and embryo transfer or
who received frozen–thawed embryos were not inclu-
ded.
Basal antral follicle measurement
The main outcome measure was the number of oo-
cytes recovered. Transvaginal ultrasound was perfor-
med on day 2–3 of the stimulation cycle, after ovarian
down-regulation and before beginning treatment with
gonadotropins. All ovarian follicles measuring 2 mm to
10 mm on both ovaries were counted by a single investi-
gator. The total number of follicles per patient was used
for calculations.
All patients were examined after spontaneous empty-
ing of the urinary bladder, lying supine with the knees
slightly bent and with a small pillow under the buttocks.
Patients were examined vaginally with an ATL (HDI
5000 diagnostic Ultrasound system; Bothell, WA; USA)
transvaginal transducer. Wall filter was set to 25–50 Hz,
and the limit of aliasing 1 cm/sec. One sonographer per-
formed all sonographic measurements.
Women undergoing ovulation induction were rou-
tinely down-regulated with triptorelin acetate (Deca-
peptyl, 0.1 mg; ER-KIM, Ilac San.; 0.1 mg/d) or busere-
line acetate SC (Suprefact 7ml; Aventis Pharma GmbH;
0.5 mg/d) starting from the 21st day of the preceding cy-
cle in long down-regulation protocol and from the 2nd
day of the cycle in the short down-regulation protocol.
The analogue was continued until the day of hCG. After
the down-regulation, ovulation induction was perfor-
med by daily injections of 150–300 IU of recombinant
FSH (Follitropin alfa; Gonal-f; Serono).
The ovulation was triggered by 10,000 IU of hCG
(Profasi, 5,000 IU ampule, Serono; or Pregnyl, 5,000 IU
amp, Organon Ilac San.), when there were at least two
leading follicles with a diameter of >18 m. After 34–36
hours, egg collection was performed by transvaginal ul-
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trasound. In vitro fertilization or intra-cytoplasmic
sperm injection and embryo transfer was performed for
all the patients. Luteal phase support was performed by
progesterone (Utrogestan, 100 mg capsules, two vaginal
capsules three times per day; Besins-I’Scovesco Lab.,
Paris, France). Embryo transfer was performed 2–5 days
after the oocyte aspiration. Embryos were classified as
previously reported
17,18
as follows: grade 1: perfectly
symmetrical with no fragmentation; grade 2: perfectly
symmetrical with slight fragmentation (<20% frag-
mentation of the total embryonic volume); grade 3: un-
even blastomeres with gross fragmentation (>20% frag-
ments). Embryos of Veeck grades 1 or 2 were consid-
ered high quality.
Two to five days after oocyte retrieval, usually three,
but occasionally two or four embryos per patient were
replaced depending on the age of the patient, the indica-
tion for IVF, the number of previous attempts, and the
number and quality of embryos available for replace-
ment.
Clinical pregnancy was defined as the presence of
gestational sac by ultrasound with appropriately rising
-hCG levels. Miscarriage was defined as pregnancy
loss before 12 weeks of gestation.
Statistical analysis
The collected data were input into a computer data-
base, pre-defined according to a specially prepared form
and software for the needs of the study. The data pro-
cessing as well as their analysis was done with the statis-
tical software »Statistica for Windows/Release 7.1«.
Data were analyzed by analysis of variance to test the
significance of means among groups, and 
2
test was
used to assess the significance of categories parameters
and pregnancy among groups. A multiple regression
analysis was performed for numerically dependent vari-
ables and a multiple logistic regression analysis was
used for a model with binomial outcomes.
Univariante analysis included regression and correla-
tion coefficients examining the association of antral fol-
licle count with measures of ovarian reserve and re-
sponse. Logistic regression was used to compare bino-
mial outcome rates with antral follicle count. Data are
reported as means ( ± SD). P < 0.05 was considered sig-
nificant.
Results
In total, 85 patients aged 24–42 years were included
in the study (Table 1).
The patients were divided into two groups according
to the total number of basal antral follicles; group 1 pa-
tients who had antral follicles 10 ( N=65) and group 2
patients who had antral follicles >10 (N=20).
There were no significant differences between either
group in patients’ age, basal levels of LH and E2 and
down –regulation days (Table 2). No cycle was canceled
after initiation of gonadotropin stimulation.
A total of 29 pregnancies resulted; a crude pregnancy
rate was 29/85 (34.12%). Of these 6/29 (20.69%) were
spontaneous abortions.
There was a significantly higher basal level of FSH in
group 1 versus group 2 (8.16±2.25 mIU/mL vs. 6.97±
1.58 mIU/mL, P<0.05, t 2.19). There were significantly
more stimulation days and total gonadotropin ampoules
needed in group 1 versus group 2 (12.31±2.48 days vs.
9.75 days±1.25, p<0.05, and 36.17±8.97 vs. 31.45±
7.34, P<0.05). There was a significantly higher number
of growing follicles of 14 mm at the time of hCG injec-
tion in group 2 versus group 1 and the number of oocytes
retrieved at follicular aspiration ( 9.00±3.03 vs. 16.65±







85 33.45 32.49 34.41 24.0 42.0 4.45
Table 2. The number of BAF. Differences between groups




Gr. 1 3–10 (n=65) Gr. 2 >10 (n=20)
Age 33.66 ± 4.56 32.75 ± 4 .10 0.79 0.43
FSH 3 day mIU/mL 8.16 ± 2.25 6.97 ± 1.58 2.19 0.03*
LH 3 day mIU/mL 5.93 ± 2.77 5.91 ± 1.95 –0.43 0.67
E2 pmol/L 35.26 ± 13.21 30.69 ± 7.31 1.45 0.15
Gonadotropin ampoule / N
o
36.17 ± 8.97 31.45 ± 7.34 –1.91 0.05*
Days of stimulation 12.31 ± 2.48 9.75 ± 1.25 –2.43 0.03*
N
o
of follicles >14 mm 9.00 ± 3.03 16.65 ± 2.70 –6.26 0.000***
N
o
of oocytes 6.55 ± 2.21 12.80 ± 2.39 –6.50 0.000***
E2 pik pmol/L 1535.86 ± 661.62 2883.50 ± 1090.07 –6.75 0.000***
N
o
ET 2.71 ± 0.74 3.15 ± 0.67 –2.09 0.04*
Pregnancies % 22 (33.85%) 7 (35.00%) 0.92
* p<0.05; *** p<0.001
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2.70, P<0.01; 6.55±2.21 vs. 12.80±2.39, P<0.001). How-
ever, women with antral follicles of 10 have a lower E
2
peak level on day of administration of hCG (1535.86 vs
2883, P<0.01).
There was a significant difference on the number of
embryos transferred between either group (2.71±0.74
vs. 3.15±0.67, P<0.04). There was not significant differ-
ence in pregnancy rates (33.85% vs. 35%, P=0.92) in
group 1 versus group 2.
The multiple regression analysis indicated that the to-
tal antral follicle count was negatively correlated with
total gonadotropin dose (ampoules) (r=–0.30; p<0.05)
meaning that for each number of antral follicles 10
women will need a 30% higher total gonadotropin dose
(Graf 2). Also multiple regression analysis indicated
that number of basal antral follicles was negatively cor-
related with the days of stimulations (r= –2.43; p<0.05)
and number of oocytes 14 (r=0.92; p<0.05) (Graf 1).
In the present study, our data showed that on day 2–3
of stimulated cycle the number of antral follicles did not
Graf 1. BAF vs N
o
oocytes 14
Grafikon 1. BAF prama broju oocita 14
Graf 2. Gonadotropin ampoules vs BAF
Grafikon 2. Ampule gonadotropina prama BAF
predict pregnancy rates in IVF/ICSI-ET cycles. No cy-
cle was canceled due to poor response despite the fact
that 76.4% of our patients had an antral follicle count of
10 (range 3–10).
Unexpectedly, the quality of embryos and day of ET
were not affected by the low antral follicle count. Obvi-
ously, the pregnancy rate is influenced by many factors
other than antral follicles count alone. We found in this
study that cycle outcome was strongly correlated with
good-quality embryos. Grade 1 embryos and day of
ET(
2
=14.48; p<0.001) were the strongest factors have
an impact on pregnancy rates (Table 3). Significantly
higher pregnancy rate was achieved after transfer of
blastocysts compared to cleavage-stage embryos
Discussion
The number of human oocytes in both ovaries de-
creases irreversibly after its formation during fetal life.
19
The total number of oocytes is approximately 6–7 mil-
lion at 16–20 weeks of gestation, 1–2 million at birth,
and 300,000 at the onset of puberty. The store of folli-
cles decreases steadily throughout a woman’s reproduc-
tive years at an assumed rate of attrition of 1,000 per
menstrual cycle. This rate is believed to be even higher
between 37.5 years of age and menopause.
20
The num-
ber of follicles leaving the pool of resting follicles to en-
ter the growth phase toward the antral stages of develop-
ment decreases with increasing age.
21
It would be helpful to have a reliable test that would
tell us how many eggs a woman has remaining at a point
in time – as well as telling us about the quality of those
eggs. The term »ovarian reserve« is useful in the field of
reproductive medicine. In other words, a woman's ovar-
ian reserve is her remaining fertility potential.
A variety of hormonal markers has been used to pre-
dict poor ovarian reserve in infertile women. Cycle day
3 FSH, E
2
, and inhibin B, as well as challenge tests, have
been studied for their predictive value. However, de-
spite their increasing acceptance in clinical practice,
these tests are far from perfect in predicting ovarian re-
sponse, cancellation rates, and ultimately, who will or
will not get pregnant.
1–12
Transvaginal ultrasonography is an accurate tool for
evaluating the ovary. Measuring the volume or maximal
diameter of both ovaries or counting the number of
small antral follicles by ultrasound has been studied as a
noninvasive and more accurate test in comparison to the
Table 3. Day of ET and pregnancy rates
Tablica 3. Dan embriotransfera i stopa trudno}a
Day of ET HCG + HCG – Total
3+4 13 47 60
15.29 55.29 70.59
5 16 9 25
18.82 10.59 29.41
Total 29 56 85
34.12 65.88 100
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in his studies demonstrated that variations in ovar-
ian measurements between examiners are very small.
Therefore, results of basal transvaginal ultrasonography
are valuable in counseling women before starting ART
cycle.
Similar to previous reports on ovarian reserve, we
found that basal antral follicle count (BAFC) is specific
but not sensitive. This characteristic makes BAFC a
good tool for counseling patients, but it cannot be used
to predict success or failure with 100% accuracy. We
also found that basal antral follicle count correlated with
the measures currently used to assess ovarian reserve
but not correlated with pregnancy outcome. These find-










We used multiple methods to attempt to limit bias. All
data were collected prospectively after obtaining patient
consent. Ultrasonography was performed by one inves-
tigator. Similar to other studies,
16,23
we found that antral
follicle number is a better prognostic indicator than age
or endocrine markers. In patients undergoing IVF-ET
program, our data also show that the antral follicle count
correlates well with ovarian response to exogenous
gonadotropin stimulation and proportionately with the
number of oocytes and the number of embryos trans-
ferred in the same cycle. As expected, the number of
antral follicles was found to be significantly correlated
with the total number of follicles 14 mm at hCG injec-
tion and this led to a significant correlation with the
number of oocytes. These findings were in agreement
with those previously reported.
13–16,23–26
To examine fur-
ther the effect of antral follicle count on pregnancy rates,
we also performed a multivariate logistic regression
analysis on the success of pregnancy, while controlling
for the number of oocytes. We failed to show any signif-
icant effect of basal antral follicle count on pregnancy
rates. The antral follicle count significantly predicted
the number of oocytes and embryos, but not the quality
of the oocytes and embryos or the success of pregnancy.
Obviously, the pregnancy rate is influenced by many
factors other than antral follicles alone. We found in this
study that cycle outcome was strongly correlated with
good-quality embryos and the day of embryo transfer.
Pregnancy, however, is largely dependent on oocyte
quality, although other factors also probably will play a
role.
23,24
In summary basal antral follicle count correlated di-
rectly with number of follicles, number of mature oo-
cytes, number of embryos and peak E
2
levels. Further-
more, basal antral follicle count correlated inversely
with ampoules of gonadotropin used, days of stimula-
tion, patient’s age, and day 3 FSH levels.
Conclusion
It is easy to count the number of antral follicles that
measure 2–10 mm just before the administration of ex-
ogenous gonadotropins. Nevertheless, transvaginal ul-
trasound ovarian measurements can predict poor re-
sponse, thereby allowing physicians to inform patients
that they are at an increased risk for poor stimulation and
cycle cancellation. Physicians can then potentially opti-
mize stimulation protocols.
Based on the results of this study, we suggest using a
higher starting dose of gonadotropin in women with an
antral follicle count of 10 and a lower starting dose of go-
nadotropin in women with an antral follicle count of >10.
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